- Monitoring Gene Therapy by Radionuclide Approaches
-
Min JJ
- KMID: 2313019
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):96-105.
Molecular imaging has its root in nuclear medicine and gene therapy monitoring. Therefore, recent progress in the development of non-invasive imaging technologies, particularly nuclear medicine, should allow molecular imaging to... -
- CITED
-
- Close
- SHARE
-
- Close
- Internal Radiation Dosimetry in Radionuclide Therapy
-
Kim KM, Lim SM
- KMID: 2313022
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):120-126.
Radionuclide therapy has been continued for treatment of incurable diseases for past decades. Relevant evaluation of absorbed dose in radionuclide therapy is important to predict treatment output and essential for... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioimmunotherapy (II): Clinical Application
-
Cheon GJ, Kang HJ, Lim SM
- KMID: 2313016
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):74-81.
Molecular targeting may be defined as the specific concentration of a diagnostic or therapeutic tracer by its interaction with a molecular species that is distinctly present or absent in a... -
- CITED
-
- Close
- SHARE
-
- Close
- Regulatory Problems in Radionuclide Therapy and Suggestions for Systematic Improvement
-
Jeong JM
- KMID: 2313013
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):53-57.
Radionuclide therapy has been used for more than 50 years and proved to be a safe and effective modality. However, the patients' right to have the excellent medical service is... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioimmunotherapy (I): Development of Radioimmunoconjugates
-
Choi TH, Lim SM
- KMID: 2313015
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):66-73.
Monoclonal antibodies are designed to bind specifically to certain antigen, give therapeutic effect to the target and to be produced in large scale with homogeneity. The monoclonal antibodies conjugated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Recent Advances in Radioiodine Therapy for Thyroid Cancer
-
Bae SK
- KMID: 2313024
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):132-140.
Well-differentiated thyroid cancer is the most common endocrine malignancy with an increasing incidence. Most patients with well-differentiated thyroid caner have a favorable prognosis with high survival rate. While surgery and... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiosynovectomy
-
Kim DY
- KMID: 2313023
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):127-131.
Radiosynovectomy has been used as an effective treatment in patients with resistant synovitis after failure of long-term medication and intraarticular steroid injection. Although 90Y silicate/citrate, 186Re sulfide, and 169Er citrate... -
- CITED
-
- Close
- SHARE
-
- Close
- Radioisotope Treatment for Benign Strictures of Non-vascular Luminal Organs
-
Shin JH
- KMID: 2313020
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):106-112.
Tissue hyperplasia is one of the most frequently encountered complications when self-expanding metallic stents are placed in benign non-vascular luminal organ strictures, thus causing restenosis of the lumen. The investigators... -
- CITED
-
- Close
- SHARE
-
- Close
- Brachytherapy in Coronary Artery Disease
-
Song HC
- KMID: 2313021
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):113-119.
Coronary artery disease is a leading cause of morbidity and mortality across the world. Percutaneous coronary intervention has become the major technique of revascularization. However, restenosis remains a major limitation... -
- CITED
-
- Close
- SHARE
-
- Close
- Review of Radionuclide Treatment for Neuroendocrine Tumors
-
Jeong HJ
- KMID: 2313018
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):90-95.
Neuroendocrine tumors (NETs) consist of a heterogeneous group of tumors that are able to uptake neuroamine and/or specific receptors, such as somatostatin receptors, which can play important roles of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic radionuclides
-
Choi SJ, Hong YD, Lee SY
- KMID: 2313014
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):58-65.
Since the development of sophisticated molecular carriers such as octereotides for peptide receptor targeting and monoclonal antibodies against various antigens associated with specific tumor types, radionuclide therapy (RNT) employing open... -
- CITED
-
- Close
- SHARE
-
- Close
- Radiopharmaceuticals for the Therapy of Metastatic Bone Pain
-
Ahn BC
- KMID: 2313017
- Nucl Med Mol Imaging.
- 2006 Apr;40(2):82-89.
Bone metastasis is a common sequelae of solid malignant tumors such as prostate, breast, lung, and renal cancers, which can lead to various complications, including fractures, hypercalcemia, and bone pain,... -
- CITED
-
- Close
- SHARE
-
- Close
